chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SHORTNESS OF BREATH AND PAIN IN THE MIDDLE F IS BACK BEHIND HEART . PATIENT HAD TO HOLD IS CHEST TO BREATHE. PATIENT HAD DIFFICULTY BREATHING FOR 4 DAYS.
This case was reported by a consumer and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, chills and joint pain. On an unknown date, the outcome of the injection site pain and joint pain were unknown and the outcome of the chills was recovered/resolved. It was unknown if the reporter considered the injection site pain, chills and joint pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient reported that she had never reacted to a vaccine before and had soreness at injection site that she expected but during the night she had 2 hours of shaking chills and her joints were extremely sore, even more sore than when she had joint replacement. The patient queried how long these side effects would last with SHINGRIX and the query was answered as the side affect from the SHINGRIX, according to the prescribing Information, could last 3 to 5 days and depends on the individual. The patient stated that this really made her not look forward to the second injection which she knew she had to receive.
Patient is an 51-year-old, male with no known medical history. Patient denies having any adverse reactions with first dose of Pfizer. On 5/21/2021 at 1:22 pm, the patient received his second dose of the Pfizer vaccine, (lot number EW0185, expires on 08/2021) on left deltoid, given by RN. Immediately after patient received injection, RN noticed the injection site swell up. Situation was elevated to RN. Patient states he feels "normal". At 1:28 pm, EMT took patient's vitals: BP 130/90, O2 98%, HR 75. RN assessed injection site. Correct area for vaccination was verified. The injection site had raised, localized swelling of about 1 inch in diameter. Patient denies pain at site. RN provided patient with education related to when to seek medical attention, including severe pain and swelling in lips or throat. The patient verbalized understanding of teaching and stated he would follow up with PCP. The patient left the facility at 1:37 pm. The patient's gait was steady and balanced. Patient denies SOB.
3.5 inches wide by 4.5 long- redness, pain, hard and painful. Lasted 10 days. Treated with ice and Ibuprofen.
Swelling/redness was reported approx. 6 days after actual immunization. Severe swelling/redness.
t103.2 on 9th day p/vax;day 10-11 diffuse rash;t98 on day 14 @ MD office;
Pt reports one day after administration of vaccines. Pt has swelling and redness at HPV injection site (Right arm) and reports flat red patches moving down upper and lower right arm. Pt states she first noticed patches when she woke up at 0600 today but disappear by 0900. No itchiness nor any other symptoms reported.
Red, swelling, rash over half of upper arm, hard lump under skin - all started after most other side effects were resolved. Injection was at or very near smallpox vaccination site - swelling, redness and itching began around that scar and has expanded to a larger part of the arm.
24 hour fever of 100. Severe body aches, chills, night sweats. Pain and stiff arm extending from shoulder to wrist and down to ribs. Still sore and stiff as of reporting.
shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced shingles that was really bad and was in the hospital. The patient asked if the patient could receive the 2nd dose of Shingrix.
PATIENT REPORTED HE WAS HOSPITALIZED FOR SECOND DOSE OF COVID SHOT & WAS ADVISED IT WAS BECAUSE OF ASTHMA.
Modern a Covid-19 vaccine Eua Tachycardia, shortness of breath, rash, lightheaded
Very sore eyes.   Twitching,  aching, could not touch them without significant pain.
Pt complained of severe pain in arm and limited motion. Treated with TYLENOL and ice packs.
Immunizations 11:30am-3 hrs later cranky with low grade fever-8:30pm-fever 102 deg, some head jerking and head rolling back and forth. Tylenol given x 2. Spoke to doctor at 12:30am and s/s decreased. Today fever NL. Re eval if any neuro s/s persist.
Persistent deep, dry cough that lasted for 6 weeks, recurrence in June 2022
A little bit of allergic reaction; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (A little bit of allergic reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (A little bit of allergic reaction). At the time of the report, HYPERSENSITIVITY (A little bit of allergic reaction) outcome was unknown.            No concomitant medication information was provided.  On an unspecified date patient received the first booster as the third dose.  No treatment medication information was provided.   This case was linked to MOD-2021-028783, MOD-2021-042448, MOD-2022-583961 (Patient Link).
Pt did not have an adverse reaction or outcome however she was dosed with Gardasil 4 on 2/9/2012, 4/17/2012, 9/10/2012 and then dosed with Gardasil 9 on 2/6/2020, 4/6/2020, 4/13/2022
nerve pain down left leg (06/19/2021)  headache, chills, stomach problems, fatigue, throat swollen, weakness(cant move)
Fever, headache & extreme fatigue, so bad I almost couldn't get out of bed the morn8ng after the shot. Headache was off an on for 6 days. Fatigue lasted about 10 hours. Fever lasted about 40 hours. Brain fog, 5 days after the shot, about 8 hours.
tested + for covid 7-4-22 at Medical Center and passed away 7-19-22.  I have no other information on this patient.
Gianotti-Crosti Syndrome occurring 3 days post immunization. Evaluated in Allergy. No exemption needed.
This spontaneous report as received from a physician, via company representative, refers to a 14 year old female patient. Pertinent medical history, drug reactions or allergies were unspecified. On 23-APR-2015 the patient was vaccinated with a second dose of GARDASIL, intramuscular, (dose, anatomical location, lot number and expiration date were not reported). Concomitant therapies were unspecified. That day, after receiving the vaccine, the patient experienced syncope (reported as "fainted"). The physician reported that the patient woke up in the office and was sent home after an unknown period of time. Treatment given for the adverse event and laboratory diagnostic studies performed were unspecified. The outcome of syncope was reported as recovered on the same day, 23-APR-2015, after an unspecified period of time. The relatedness between syncope and GARDASIL was not reported. Additional information has been requested.
pt recvd vax; devel cellulitis at inject site; no cultures done; tx w/ atbs; also exp inject site pain & tenderness & fever;
Pain at injection site, fatigue lasting several days and intermittent nausea, mild sore throat and some dry coughing. The pain in arm is 90% reduced. Fatigue was moderate 1-3 days after injection but still persists and is currently mild.
Information has been received from a pharmacist concerning a 63 year old female who was vaccinated with a first 0.5 ml dose of Zostavax. It was reported that in a day or two after vaccination the patient developed "bumps that resembled a rash" around the injection site. The patient rubbed BENADRYL on the "bumps" and it went away. Unspecified medical attention was sought. At the time of report the patient had recovered. A product quality complaint was not involved. Additional information has been requested.
Modera COVID-19 Vaccine, chest pain, heart pain, heart congestion, headache continuous for weeks
5 min after receiving , she started getting pain in her arm (right side) Hands felt like they were cramping. Fingers then started to feel tingly into her arms. Then lead to hard time swallowing. Did have some dizziness. Legs felt weak as well. She was given epinephrine per Doctor order. Was transferred to ER. They did give her Benadryl she had some slight bumps around mouth and neck.
ITCHY RASH BEGAN ON FRONT OF LEGS AND MOVED TO THE PATIENT'S BACK AND SPREAD AROUND THE TRUNK AREA ON 4/5/21. RASH ALSO APPEARED IN ELBOW CREASES AND ON ARMS. PATIENT WENT TO THE DOCTOR THE FOLLOWING SATURDAY BECAUSE BENADRYL USE WAS NOT HELPING/ONLY HELPING MINIMALLY...DOCTOR VISIT WAS ON ON 4/10/21 AND WAS PRESCRIBED HYDROXYZINE  FOR ITCHING AND A PREDNISONE  6-DAY TAPERED DOSE. PATIENT REPORTS PREDNISONE HELPED A LITTLE BIT BUT RASH AND ITCHING CONTINUES TO FLARE UP. PATIENT BELIEVES IT MAY BE ENSURE, AS SHE BEGAN DRINKING IT FOR THE FIRST TIME AROUND VACCINATION TIME. SHE WILL CONTINUE TO FOLLOW UP WITH PRIMARY CARE PHYSICAN.
2 bouts of diarrhea; bad heartburn; really bad headache; fever of 101.7/Fever of 100.0; chills; body aches; This is a spontaneous report from a contactable Other Health Professional (patient). A 31-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in left arm on 05Jan2021 13:00 at single dose for COVID-19 immunization.  Medical history was none (known allergies: No, other medical history: None).  Concomitant medication in two weeks included escitalopram oxalate (LEXAPRO). The patient experienced really bad headache, fever of 101.7/fever of 100.0, chills, body aches, all on 10Jan2021 11:00 with outcome of recovering, 2 bouts of diarrhea and bad heartburn on 11Jan2021 with outcome of recovering.  The patient underwent lab tests and procedures which included body temperature: 100 in Jan2021, 101.7 on 10Jan2021, Nasal Swab (Sars CoV-2 nucleic acid amplified test): negative on 10Jan2021. On 10Jan2021 11 am developed really bad headache, fever of 101.7, chills and body aches. On 11Jan2021 morning symptoms slowly improving with paracetamol (TYLENOL) but developed bad heartburn and 2 bouts of diarrhea. Fever of 100.0. No treatment received for heartburn and 2 bouts of diarrhea. AE resulted in: Doctor or other healthcare professional office/clinic visit. Facility type vaccine: Hospital. if other vaccine in four weeks: No. If treatment AE: No. If COVID prior vaccination: No. If COVID tested post vaccination: Yes.  information on the Lot/Batch number has been requested.
Information has been received from a consumer concerning her child was vaccinated PO with a first 2 ml dose of Rotateq (human-bovine). Subsequently the patient experienced a distinctive hard belly and had not had a bowel movement in 3 days. Unspecified medical attention was sought. Additional information has been requested. 29-OCT-2009 Follow-up information indicated that it was "not an anticipation". Additional information is not expected.
With the first injection exactly 6 months prior and this injection, I feel like I have the flu for a day. My normal temp runs a bit low and both times after the injection I have a temp of 99^.  My arm is sore which is understandable but I wanted to report feeling so sluggish with a low grade fever, especially since it has happened both times.
p/ pt recv vax exp breakthrough varicella, itchy rash for 24 hr w/multiple bite-like red papules pt sought md attention
Patient was age 17 years old when given the 1st dose of the Moderna vaccine and discrepency in age was only noted about patient's following visit for her  birth control measures. Pt and mother were informed and are aware, was advised to still complete series of vaccination and returned for 2nd dose. Pt had no adverse reaction and completed her 2nd dose in office as well, but must be noted that it was given to someone below the age group so reported to VAERS.
Last year, the patient received an unspecified influenza vaccine (manufacturer unknown). After receiving the influenza vaccine, the patient 'went into a coma' on an unknown date. Unspecified treatment was given for the adverse event. The patient fully recovered from the event. The reporter considered event serious due to hospitalisation.
almost pass out; Chills; nausea; diarrhea; abdominal pain; clammy; elevated heart rate; dizzy; This is a spontaneous report from a contactable consumer (patient's parent). A 24-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via an unspecified route of administration on left arm on an unspecified date in Dec2020 at single dose for COVID-19 immunization. The relevant medical history included asthma, migraines and anxiety all from an unspecified date. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING), topiramate (TOPAMAX), verapamil and sertraline hydrochloride (ZOLOFT). The patient experienced chills, nausea, diarrhea, abdominal pain, clammy, elevated heart rate, almost pass out, dizzy, all on 05Jan2021. The patient had no treatment for the events. No covid prior vaccination. The patient underwent lab test included heart rate showed elevated on 05Jan2021, Nasal Swab showed negative on 06Jan2021. The outcome of the events was not recovered.
As stated in Block 17, i received my second COVID vaccine dose on March 13 2021 after receiving my first dose on February 13 2021. Both doses were administered at the Medical Center. I had no adverse affect after the first dose but exactly three days after my second dose, 3/16/21, I developed hives, welts,and large areas of itchy rash over my entire body from my scalp to my feet. This was accompanied by general fatigue and several instances of uncontiousness. Within two days I reported this directly to my doctor, and was dismissed as "just seasonal allergies". As I had never had any condition such as this and as a matter of fact was quite healthy  Prior to this, I knew this to be totally incorrect.  Getting progressively more ill very quickly, I was passed off to a series of outside doctors (9 in total) including allergists, multiple dermatologists and even a very long trip to the Medical Center (authorized but at my expense) no help or determination was made although I continued to grow quite ill. On two occasions, my wife has had to rush me to the emergency room. I was experiencing severe rash, hives, shortness of breath and feeling extremely tired.  No help was forthcoming and was dismissed to recover at home. Very difficult situations.  In 2021, I went to NP, as she is my usual physician for general issues. Tests were performed and preliminary results showed strong reaction to mammal products as well as some "unusual"chemical levels. NP then referred me to Dr., as she is a specialist in allergic type reactions.  So during 2021 and into 2022, I was seen by Dr. multiple times for testing and consultations. Often while I was having an attack. Testing showed, again, allergic reactions to mammal products as well as unusual chemical levels in my blood. At this time, 2022, Dr. referred me to Dr. at  Dermatology for furher specific testing.  Late in 2022, the final diagnosis was made of " Post COVID Vaccine Chronic Urticaria and Anaphylaxis". This has been caused by severe allergic reactions to PEG which is evidently contained in vaccines. His diagnosis has led me, finally, to monthly injections of XOLAIR as well as maintaining large doses of anti-histemines. I still experience the usual dermatology symptoms, although on a much reduced scale and havent had the occurances of "passing out" as before.  My wife and I are having to avoid anything that has any mammal based products and / or more importantly, anything with PEG or related products. This is quite difficult and has greatly affected our quality of life to the extent that we have had to stop traveling for fear of coming into contact with any of these factors.  Having never had any such illness prior to the vaccine injections, we are at a loss at what to do going forward and feel like we are just being moved from doctor to doctor without getting any resolution to my condition. This is un-acceptable.
Information has been received from a nurse practitioner (Pharm. D.) concerning a male who on 23-NOV-2010 was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 (lot # not reported). The reporter stated that the patient experienced a rash and hives after receiving PNEUMOVAX 23 in November 2010 ("a couple days after 23-NOV-2010"). The patient was treated with steroid cream. At the time of reporting, the patient had not recovered from a rash and hives. The patient sought unspecified medical attention. Follow up information has been received from a pharmacist student concerning a male patient who on 23-NOV-2010 was vaccinated with the first 0.5 ml dose of PNEUMOVAX 23 (lot # not reported). The reporter stated that about 2 weeks after vaccination (also reported as "a couple days after 23-NOV-2010" by the nurse), the patient developed a generalized rash with urticaria. The patient was treated with steroid cream. At the time of reporting, the patient had not recovered from a generalized rash with urticaria. The patient sought unspecified medical attention. Additional information has been requested.
Low grade fever, body aches, fatigue, lethargy, tingling in all extremities and head.
Numbness/tingling in left arm. Occurs from upper left arm, through elbow, down to finger tips. Numbness and tingling are present in all fingers on the left hand, more it is more prominent moving towards the pinky/ulnar side of the hand. I?ve also had a lot of pain and tenderness in the axillary/armpit area of my left arm. This was stronger in the 24-72hrs post vaccination with both doses of the COVID vaccine.   Numbness in tongue, lips, and throat in the 15 minutes after getting both doses of the COVID vaccine.
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Experiencing cough after receiving the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Experiencing cough after receiving the Moderna vaccine). At the time of the report, COUGH (Experiencing cough after receiving the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow up received on 10-Aug-2021 and included No new information.
I had itchy red skin on my legs,arms,and face. Took benadryl  at 6pm. After benadryl wore off still had some irritation on my skin and itchyness.
Pt developed erythema and induration at right upper arm below DTAP vaccination point. Range of motion (+).
Information has been received from an office manager concerning an 18 year old female who on 27-JUL-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast). After receiving the first dose, the patient's arm was sore. On 29-JUL-2008 the patient came back to the office and was vaccinated with the second dose of GARDASIL vaccine (yeast), which was almost a year later. Concomitant therapy included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. On the same day, after receiving the second dose, the patient was a little dizzy so she waited for a while until she felt better. The patient was fully recovered on that day. The patient sought unspecified medical attention. Additional information has been requested.
Shoulder pain; So tired and didn't want to do anything/Laid in bed; Extra doses administered; Extra doses administered; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 2 doses in last year from the reporting date ).   In April 2019, the patient received the 3rd dose of Shingrix (intramuscular). In September 2019, the patient received the 4th dose of Shingrix. In April 2019, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced extra dose administered. In September 2019, the patient experienced shoulder pain, tiredness and extra dose administered. On an unknown date, the outcome of the shoulder pain, tiredness, extra dose administered and extra dose administered were unknown.   It was unknown if the reporter considered the shoulder pain and tiredness to be related to Shingrix.  Additional details were received as follows: The age vaccination was not reported. The patient again received both doses of Shingrix this year, which led to extra dose administered. The reporter couldn't remember the dates of her first injections last year, however, she received one dose this past week and then five months prior she received the other dose.  When the reporter inquired if she remembered the dates of the vaccination from last year, she stated that she was losing her memory a little and couldn't remember.  She also reported that after the second dose of the Shingrix this year, she laid in bed the next day from shoulder pain and she was in bed all day and was so tired and she didn't want to do anything but then the issues resolved.   The reporter consented to follow up. The patient requested to remain anonymous.
Congestion; Body ache; High feve /Body temperature 100 F; Cough; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), NASAL CONGESTION (Congestion), MYALGIA (Body ache), HEADACHE (Headache) and PYREXIA (High feve /Body temperature 100 F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for Prophylactic vaccination.     Previously administered products included for Prophylactic vaccination: JANSSEN (Dose number in series 1, batch number: 1805031 and Route: right arm.) on 15-Mar-2021. Past adverse reactions to the above products included No adverse event with JANSSEN.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2021, the patient experienced COUGH (Cough) and HEADACHE (Headache). On 31-Dec-2021, the patient experienced NASAL CONGESTION (Congestion) and MYALGIA (Body ache). 31-Dec-2021, the patient experienced PYREXIA (High feve /Body temperature 100 F). On 02-Jan-2022, MYALGIA (Body ache), HEADACHE (Headache) and PYREXIA (High feve /Body temperature 100 F) had resolved. At the time of the report, COUGH (Cough) and NASAL CONGESTION (Congestion) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2021, SARS-CoV-2 test: negative (Negative) Negative. On 31-Dec-2021, Body temperature: 100 (High) 100  Fahrenheit.         Lab test: COVID 19 polymerase chain reaction (PCR) test : Awaiting result.  No treatment medication was reported.